Page last updated: 2024-11-07

spironolactone and Emphysema, Mediastinal

spironolactone has been researched along with Emphysema, Mediastinal in 1 studies

Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.

Research Excerpts

ExcerptRelevanceReference
"Pneumomediastinum is an uncommon disease arising most frequently and remains largely underdiagnosed clinically, especially in young, healthy patients."1.38Pneumomediastinum after retching. ( Al, B; Genc, S; Murat, Ç; Sanli, M; Yildirim, C; Zengin, S, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Al, B1
Yildirim, C1
Zengin, S1
Murat, Ç1
Genc, S1
Sanli, M1

Other Studies

1 other study available for spironolactone and Emphysema, Mediastinal

ArticleYear
Pneumomediastinum after retching.
    BMJ case reports, 2012, Oct-10, Volume: 2012

    Topics: Adult; Female; Hirsutism; Humans; Mediastinal Emphysema; Mineralocorticoid Receptor Antagonists; Rad

2012